PT Kimia Farma Tbk (IDX:KAEF)
436.00
0.00 (0.00%)
Sep 2, 2026, 11:59 AM WIB
PT Kimia Farma Tbk Revenue
PT Kimia Farma Tbk had revenue of 2.67T IDR in the quarter ending June 30, 2026, with 21.35% growth. This brings the company's revenue in the last twelve months to 9.56T, up 5.07% year-over-year. In the year 2025, PT Kimia Farma Tbk had annual revenue of 9.22T, down -7.20%.
Revenue (ttm)
9.56T
Revenue Growth
+5.07%
P/S Ratio
0.25
Revenue / Employee
1.02B
Employees
9,361
Market Cap
2.43T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.22T | -715.63B | -7.20% |
| Dec 31, 2024 | 9.94T | 67.12B | 0.68% |
| Dec 31, 2023 | 9.87T | 639.17B | 6.92% |
| Dec 31, 2022 | 9.23T | -3,624.95B | -28.19% |
| Dec 31, 2021 | 12.86T | 2.85T | 28.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Enseval Putera Megatrading Tbk. | 35.18T |
| PT Medela Potentia Tbk | 15.64T |
| PT Soho Global Health Tbk | 10.97T |
| PT Millennium Pharmacon International Tbk | 4.30T |
| PT Itama Ranoraya Tbk | 1.05T |
| PT Esa Medika Mandiri Tbk | 504.59B |
| PT Diastika Biotekindo Tbk | 205.27B |